Products for Research Use Only

Simtuzumab

CAT: 1410-M36673-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M36673-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Simtuzumab is a monoclonal antibody against lysyl oxidase-like protein 2 (LOXL2) . Simtuzumab can be used to treat primary sclerosing cholangitis (PSC) and is not effective in patients with bridging fibrosis or compensatory cirrhosis caused by non-alcoholic steatohepatitis.
CAS Number
1318075-13-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Monoamine Oxidase

Chemical Information

Simtuzumab

Simtuzumab has been used in trials studying the treatment and basic science of Myelofibrosis, Pancreatic Cancer, Colorectal Cancer, and Idiopathic Pulmonary Fibrosis.

CAS Number1318075-13-6
PubChem CID17750227
IUPAC Name4-borono-3-chlorobenzoic acid
Molecular FormulaC7H6BClO4
Molecular Weight200.38
Topological Polar Surface Area77.8
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Heavy Atom Count13
Formal Charge0
Complexity199
SMILES
B(C1=C(C=C(C=C1)C(=O)O)Cl)(O)O
InChI
InChI=1S/C7H6BClO4/c9-6-3-4(7(10)11)1-2-5(6)8(12)13/h1-3,12-13H,(H,10,11)
InChIKey
FYDHSNLXZRGWFU-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Simtuzumab
CAS: 1318075-13-6
CID: 17750227
Formula: C7H6BClO4
MW: 200.38
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight200.38
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count4
Rotatable Bond Count2
Exact Mass200.0047665
Monoisotopic Mass200.0047665
Topological Polar Surface Area77.8 Ų
Heavy Atom Count13
Formal Charge0
Complexity199
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Popular Products